Riverwater Partners’s Idexx Laboratories IDXX Stock Holding History

Riverwater Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-354	Closed	-$226K	–	219
2025 Q3	$226K	Buy	+354	New	+$215K	0.09%	204

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Riverwater Partners's IDXX Position: Q4 2025 in Review

Riverwater Partners sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 354 shares — an estimated $226K sold.

Riverwater Partners first reported a position in IDXX in Q3 2025 and held it in 1 quarter. The position peaked at $226K in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

Riverwater Partners reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
Riverwater Partners sold 354 Idexx Laboratories shares in Q4 2025, an estimated $226K.
Riverwater Partners first reported a position in Idexx Laboratories in Q3 2025 and held it in 1 quarter.
Riverwater Partners's Idexx Laboratories position peaked at $226K in Q3 2025.
1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Riverwater Partners's 13F filing for Q4 2025, filed 12 Feb 2026.